Below are the most recent publications written about "Liver Function Tests" by people in Profiles.
-
Bloom PP, Pasricha TS, Andersson KL, Pratt DS, Hashemi N, Bhan I, Viveiros K. Hepatology Consultants Often Disagree on Etiology of Abnormal Liver Biochemistries in COVID-19 but Agree on Management. Dig Dis Sci. 2021 06; 66(6):1852-1854.
-
SoRelle JA, Jiao R, Gao E, Veazey J, Frame I, Quinn AM, Day P, Pagels P, Gimpel N, Patel K. Impact of Hormone Therapy on Laboratory Values in Transgender Patients. Clin Chem. 2019 01; 65(1):170-179.
-
Martins PN, Rawson A, Movahedi B, Br?ggenwirth IMA, Dolgin NH, Martins AB, Mahboub P, Bozorgzadeh A. Single-Center Experience With Liver Transplant Using Donors With Very High Transaminase Levels. Exp Clin Transplant. 2019 08; 17(4):498-506.
-
Harman A, Chang KJ, Dupuy D, Rintels P. The long-lasting effect of ferumoxytol on abdominal magnetic resonance imaging. J Comput Assist Tomogr. 2014 Jul-Aug; 38(4):571-3.
-
Ambade A, Catalano D, Lim A, Kopoyan A, Shaffer SA, Mandrekar P. Inhibition of heat shock protein 90 alleviates steatosis and macrophage activation in murine alcoholic liver injury. J Hepatol. 2014 Oct; 61(4):903-11.
-
Sokolove J, Strand V, Greenberg JD, Curtis JR, Kavanaugh A, Kremer JM, Anofrei A, Reed G, Calabrese L, Hooper M, Baumgartner S, Furst DE. Risk of elevated liver enzymes associated with TNF inhibitor utilisation in patients with rheumatoid arthritis. Ann Rheum Dis. 2010 Sep; 69(9):1612-7.
-
Dunzendorfer T, Mansani S, Pleskow D. Reversible ischemic sclerosing cholangiopathy. Am J Gastroenterol. 2008 May; 103(5):1314-5.
-
Utsunomiya T, Okamoto M, Wakiyama S, Hashimoto M, Fukuzawa K, Ezaki T, Aishima S, Yoshikawa Y, Hanai T, Inoue H, Barnard GF, Mori M. A specific gene-expression signature quantifies the degree of hepatic fibrosis in patients with chronic liver disease. World J Gastroenterol. 2007 Jan 21; 13(3):383-90.
-
Nunes D, Fleming C, Offner G, O'Brien M, Tumilty S, Fix O, Heeren T, Koziel M, Graham C, Craven DE, Stuver S, Horsburgh CR. HIV infection does not affect the performance of noninvasive markers of fibrosis for the diagnosis of hepatitis C virus-related liver disease. J Acquir Immune Defic Syndr. 2005 Dec 15; 40(5):538-44.
-
Dickerman RD, Pertusi RM, Zachariah NY, Dufour DR, McConathy WJ. Anabolic steroid-induced hepatotoxicity: is it overstated? Clin J Sport Med. 1999 Jan; 9(1):34-9.